Insider · CIK 0001831215

Horn Kinney

Reports to the SEC for 2 companies · BOTHELL, WA

sec.gov

Transactions

Companies

Filings

CIK

0001831215

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-04	IMNMImmunome Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−50.4K sh	—	—	78,542
2026-08-04	IMNMImmunome Inc.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+50.4K sh	$12.92	+$651K	50,366
2026-08-04	IMNMImmunome Inc.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+40.3K sh	$10.60	+$427K	90,616
2026-08-04	IMNMImmunome Inc.S Sale	CHIEF BUSINESS OFFICER	SSale	−90.6K sh	$25.09	−$2.27M	0
2026-08-04	IMNMImmunome Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−40.3K sh	—	—	120,750
2026-07-23	IMNMImmunome Inc. · Employee Stock Option (right to buy)A Award	CHIEF BUSINESS OFFICER	AAward	+62.5K sh	—	—	62,500
2026-07-23	IMNMImmunome Inc.A Award	CHIEF BUSINESS OFFICER	AAward	+31.3K sh	—	—	31,250
2026-07-07	IMNMImmunome Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	−1,092 sh	—	—	128,908
2026-07-07	IMNMImmunome Inc.M Exercise/Conversion	CHIEF BUSINESS OFFICER	MExercise/Conversion	+1,092 sh	$12.92	+$14.1K	1,092
2026-07-07	IMNMImmunome Inc.S Sale	CHIEF BUSINESS OFFICER	SSale	−1,092 sh	$25.00	−$27.3K	0
2025-07-29	IMNMImmunome Inc. · Employee Stock Option (right to buy)A Award	CHIEF BUSINESS OFFICER	AAward	+161K sh	—	—	161,000
2024-08-09	IMNMImmunome Inc. · Stock option (right to buy)A Award	CHIEF BUSINESS OFFICER	AAward	+130K sh	—	—	130,000
2024-02-20	IMNMImmunome Inc. · Stock option (right to buy)A Award	CHIEF BUSINESS OFFICER	AAward	+300K sh	—	—	300,000
2023-02-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+150K sh	—	—	150,000
2022-03-10	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,253 sh	—	—	141,785
2022-03-10	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,253 sh	$2.06	+$10.8K	7,711
2022-03-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−5,253 sh	$4.75	−$25K	2,458
2022-02-10	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,251 sh	—	—	147,038
2022-02-10	OLMAOlema Pharmaceuticals, Inc.D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−5,251 sh	—	—	2,458
2022-02-10	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,251 sh	$2.06	+$10.8K	7,709
2022-02-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+133K sh	—	—	133,000
2022-01-10	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,251 sh	$2.06	+$10.8K	7,709
2022-01-10	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,251 sh	—	—	152,289
2022-01-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−5,251 sh	$6.85	−$36K	2,458
2021-12-10	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,251 sh	—	—	157,540
2021-12-10	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,251 sh	$2.06	+$10.8K	7,709
2021-12-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−5,251 sh	$10.39	−$54.6K	2,458
2021-11-10	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+22.4K sh	$19.00	+$426K	29,458
2021-11-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−27.7K sh	$26.88	−$744K	1,790
2021-11-10	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,251 sh	—	—	162,791
2021-11-10	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−22.4K sh	—	—	67,253
2021-11-10	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,251 sh	$2.06	+$10.8K	7,041
2021-10-11	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−3,146 sh	$28.19	−$88.7K	1,790
2021-10-11	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,251 sh	$2.06	+$10.8K	7,041
2021-10-11	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−2,105 sh	$27.47	−$57.8K	4,936
2021-10-11	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,251 sh	—	—	168,042
2021-09-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−5,251 sh	$29.38	−$154K	1,790
2021-09-10	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,251 sh	$2.06	+$10.8K	7,041
2021-09-10	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,251 sh	—	—	173,293
2021-08-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−5,191 sh	$25.70	−$133K	1,850
2021-08-10	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,251 sh	—	—	178,544
2021-08-10	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,251 sh	$2.06	+$10.8K	7,041
2021-08-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−60 sh	$26.17	−$1,570.2	1,790
2021-07-12	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−1,392 sh	$27.00	−$37.6K	1,790
2021-07-12	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,251 sh	$2.06	+$10.8K	7,041
2021-07-12	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,251 sh	—	—	183,795
2021-07-12	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−3,859 sh	$26.33	−$102K	3,182
2021-06-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−2,164 sh	$29.60	−$64.1K	4,577
2021-06-10	OLMAOlema Pharmaceuticals, Inc.S Sale	Chief Business Officer	SSale	−2,787 sh	$29.97	−$83.5K	1,790
2021-06-10	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,251 sh	—	—	189,046

Recent filings

Accepted (ET)
Aug 64
Horn Kinney0001831215-26-000005
SEC(opens sec.gov)
Jul 274
Horn Kinney0001831215-26-000004
SEC(opens sec.gov)
Jul 94
Horn Kinney0001831215-26-000002
SEC(opens sec.gov)
Jul 314
Horn Kinney0001415889-25-020785
SEC(opens sec.gov)
Aug 134
Horn Kinney0001415889-24-021236
SEC(opens sec.gov)
Feb 214
Horn Kinney0001415889-24-004704
SEC(opens sec.gov)
Feb 24
Horn Kinney0001209191-23-006285
SEC(opens sec.gov)
Mar 144
Horn Kinney0001415889-22-002936
SEC(opens sec.gov)
Feb 144
Horn Kinney0001415889-22-001314
SEC(opens sec.gov)

Companies

Address

C/O IMMUNOME, INC. 18702 N. CREEK PARKWAY, SUITE 100

BOTHELL, WA, 98011